In contrast, elevated anti-MAG IgM titers in serum are predominantly associated with the distinct peripheral demyelinating disorder anti-MAG neuropathy [61], making a direct pathological relevance of anti-MAG antibodies in MS improbable. This evidence concerns the gene CD40LG and myeloid sarcoma.